Similar articles

• Immunologic status before and during immunotherapy (immuneprofile).

  Alth G, Denck H, Fischer M, Karrer K, Kokron O, Korizek E, Micksche M, Ogris E, Reider C, Titscher R, Wrba H. Alth G, et al. Cancer Chemother Rep 3. 1973 Mar;4(2):275-7. Cancer Chemother Rep 3. 1973. PMID: 4729329 No abstract available.
• Immunological activity of blood lymphocyte fractions. A study by the macrophage electrophoretic mobility method.

  Minderhoud JM, Smith JK. Minderhoud JM, et al. Clin Exp Immunol. 1972 Apr;10(4):571-9. Clin Exp Immunol. 1972. PMID: 5034245 Free PMC article.
• Studies on specificity of cell-mediated immunity to human tumors.

  Takasugi M, Mickey MR, Terasaki PI. Takasugi M, et al. J Natl Cancer Inst. 1974 Dec;53(6):1527-38. J Natl Cancer Inst. 1974. PMID: 4140237 No abstract available.
• [Immunological approaches to the treatment of solid tumors].

  May-Levin F. May-Levin F. Boll Ist Sieroter Milan. 1971 May-Jun;50(3):221-30. Boll Ist Sieroter Milan. 1971. PMID: 4111987 Review. French. No abstract available.
• Viral and immunologic studies of human neoplasms.

  Malmgren RA, Morton DL. Malmgren RA, et al. Pathobiol Annu. 1971;1:63-81. Pathobiol Annu. 1971. PMID: 4359566 Review. No abstract available.